These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ; JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075 [TBL] [Abstract][Full Text] [Related]
4. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510 [TBL] [Abstract][Full Text] [Related]
5. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G; JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398 [TBL] [Abstract][Full Text] [Related]
6. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry. Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R; JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609 [TBL] [Abstract][Full Text] [Related]
7. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry. Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes With Transcatheter Aortic Valve Replacement in Women Compared With Men: Evidence From a Meta-Analysis. Saad M; Nairooz R; Pothineni NVK; Almomani A; Kovelamudi S; Sardar P; Katz M; Abdel-Wahab M; Bangalore S; Kleiman NS; Block PC; Abbott JD JACC Cardiovasc Interv; 2018 Jan; 11(1):24-35. PubMed ID: 29055767 [TBL] [Abstract][Full Text] [Related]
9. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve. Pibarot P; Hahn RT; Weissman NJ; Arsenault M; Beaudoin J; Bernier M; Dahou A; Khalique OK; Asch FM; Toubal O; Leipsic J; Blanke P; Zhang F; Parvataneni R; Alu M; Herrmann H; Makkar R; Mack M; Smalling R; Leon M; Thourani VH; Kodali S JAMA Cardiol; 2017 Nov; 2(11):1208-1216. PubMed ID: 28973091 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T; Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258 [TBL] [Abstract][Full Text] [Related]
11. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: Insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). Williams M; Kodali SK; Hahn RT; Humphries KH; Nkomo VT; Cohen DJ; Douglas PS; Mack M; McAndrew TC; Svensson L; Thourani VH; Tuzcu EM; Weissman NJ; Kirtane AJ; Leon MB J Am Coll Cardiol; 2014 Apr; 63(15):1522-8. PubMed ID: 24561149 [TBL] [Abstract][Full Text] [Related]
12. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR; Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231 [TBL] [Abstract][Full Text] [Related]
13. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial. Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ; JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004 [TBL] [Abstract][Full Text] [Related]